Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

NCT02651376 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus
Immunodeficiency

Interventions

COMBINATION_PRODUCT: Conventional plus AAIT

Sponsor

Beijing 302 Hospital